Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

[Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].

Quera-Salva MA, Claustrat B.

Encephale. 2018 Dec;44(6):548-557. doi: 10.1016/j.encep.2018.06.005. Epub 2018 Aug 11. French.

PMID:
30107892
2.

Circadian Rhythm Disturbances in the Blind.

Hartley S, Dauvilliers Y, Quera-Salva MA.

Curr Neurol Neurosci Rep. 2018 Aug 6;18(10):65. doi: 10.1007/s11910-018-0876-9. Review.

PMID:
30083814
3.

Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management.

Quera Salva MA, Hartley S, Léger D, Dauvilliers YA.

Front Neurol. 2017 Dec 18;8:686. doi: 10.3389/fneur.2017.00686. eCollection 2017. Review.

4.

Spasticity or periodic limb movements?

Levy J, Hartley S, Mauruc-Soubirac E, Leotard A, Lofaso F, Quera-Salva MA, Bensmail D.

Eur J Phys Rehabil Med. 2018 Oct;54(5):698-704. doi: 10.23736/S1973-9087.17.04886-9. Epub 2017 Dec 4.

5.

Prognostic value of nocturnal hypoventilation in neuromuscular patients.

Orlikowski D, Prigent H, Quera Salva MA, Heming N, Chaffaut C, Chevret S, Annane D, Lofaso F, Ogna A.

Neuromuscul Disord. 2017 Apr;27(4):326-330. doi: 10.1016/j.nmd.2016.12.006. Epub 2016 Dec 21.

PMID:
28153460
6.

Association between reported sleep need and sleepiness at the wheel: comparative study on French highways between 1996 and 2011.

Quera-Salva MA, Hartley S, Sauvagnac-Quera R, Sagaspe P, Taillard J, Contrand B, Micoulaud JA, Lagarde E, Barbot F, Philip P.

BMJ Open. 2016 Dec 21;6(12):e012382. doi: 10.1136/bmjopen-2016-012382.

7.

French consensus. Idiopathic hypersomnia: Investigations and follow-up.

Leu-Semenescu S, Quera-Salva MA, Dauvilliers Y.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):32-37. doi: 10.1016/j.neurol.2016.09.015. Epub 2016 Nov 10. Review.

PMID:
27838089
8.

Utility of the bispectral index for assessing natural physiological sleep stages in children and young adults.

Benissa MR, Khirani S, Hartley S, Adala A, Ramirez A, Fernandez-Bolanos M, Quera-Salva MA, Fauroux B.

J Clin Monit Comput. 2016 Dec;30(6):957-963. Epub 2015 Oct 29.

PMID:
26515742
9.

Prognostic Value of Initial Assessment of Residual Hypoventilation Using Nocturnal Capnography in Mechanically Ventilated Neuromuscular Patients: A 5-Year Follow-up Study.

Ogna A, Nardi J, Prigent H, Quera Salva MA, Chaffaut C, Lamothe L, Chevret S, Annane D, Orlikowski D, Lofaso F.

Front Med (Lausanne). 2016 Sep 13;3:40. doi: 10.3389/fmed.2016.00040. eCollection 2016.

10.

Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies.

Leger D, Quera-Salva MA, Vecchierini MF, Ogrizek P, Perry CA, Dressman MA.

Expert Opin Drug Saf. 2015;14(11):1673-85. doi: 10.1517/14740338.2015.1093112. Epub 2015 Sep 22.

PMID:
26393492
11.

Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature.

Ogna A, Quera Salva MA, Prigent H, Mroue G, Vaugier I, Annane D, Lofaso F, Orlikowski D.

Sleep Breath. 2016 May;20(2):575-81. doi: 10.1007/s11325-015-1247-2. Epub 2015 Sep 4. Review.

PMID:
26338464
12.

Sleep disorders, sleepiness, and near-miss accidents among long-distance highway drivers in the summertime.

Quera Salva MA, Barbot F, Hartley S, Sauvagnac R, Vaugier I, Lofaso F, Philip P.

Sleep Med. 2014 Jan;15(1):23-6. doi: 10.1016/j.sleep.2013.06.018. Epub 2013 Sep 14.

PMID:
24286897
13.

Combined caffeine and bright light reduces dangerous driving in sleep-deprived healthy volunteers: a pilot cross-over randomised controlled trial.

Hartley SL, Barbot F, Machou M, Lejaille M, Moreau B, Vaugier I, Lofaso F, Quera-Salva MA.

Neurophysiol Clin. 2013 Jun;43(3):161-9. doi: 10.1016/j.neucli.2013.04.001. Epub 2013 Apr 26.

PMID:
23856172
14.

The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M.

Int J Mol Sci. 2013 Jun 13;14(6):12458-83. doi: 10.3390/ijms140612458. Review.

15.

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.

Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S.

CNS Spectr. 2013 Jun;18(3):163-70. doi: 10.1017/S1092852913000060. Epub 2013 Mar 11.

PMID:
23472671
16.

Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.

Kasper S, Corruble E, Hale A, Lemoine P, Montgomery SA, Quera-Salva MA.

Int Clin Psychopharmacol. 2013 Jan;28(1):12-9. doi: 10.1097/YIC.0b013e328359768e.

PMID:
23023074
17.

Efficiency of invasive mechanical ventilation during sleep in Duchenne muscular dystrophy.

Nardi J, Prigent H, Garnier B, Lebargy F, Quera-Salva MA, Orlikowski D, Lofaso F.

Sleep Med. 2012 Sep;13(8):1056-65. doi: 10.1016/j.sleep.2012.05.014. Epub 2012 Jul 25.

PMID:
22841025
18.

Nocturnal hypoxemia, but not hypercapnia, correlates with sleep quality in children.

Krivec U, Quéra Salva MA, Constant I, Ramirez A, Lofaso F, Pépin JL, Fauroux B.

Respir Care. 2012 Nov;57(11):1937-44. doi: 10.4187/respcare.01771. Epub 2012 Jun 15.

19.

Nocturnal oximetry and transcutaneous carbon dioxide in home-ventilated neuromuscular patients.

Nardi J, Prigent H, Adala A, Bohic M, Lebargy F, Quera-Salva MA, Orlikowski D, Lofaso F.

Respir Care. 2012 Sep;57(9):1425-30. doi: 10.4187/respcare.01658. Epub 2012 Feb 17.

20.

Mood disorders, circadian rhythms, melatonin and melatonin agonists.

Quera Salva MA, Hartley S.

J Cent Nerv Syst Dis. 2012 Jan 4;4:15-26. doi: 10.4137/JCNSD.S4103. Print 2012.

Supplemental Content

Loading ...
Support Center